Alcon Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON, and when can generic versions of ALCON drugs launch?
ALCON has fifty-seven approved drugs.
There are thirty-nine US patents protecting ALCON drugs. There is one tentative approval on ALCON drugs.
There are two hundred and sixteen patent family members on ALCON drugs in thirty-one countries and seventy-eight supplementary protection certificates in fourteen countries.
Summary for Alcon
International Patents: | 216 |
US Patents: | 39 |
Tradenames: | 48 |
Ingredients: | 40 |
NDAs: | 57 |
Patent Litigation for Alcon: | See patent lawsuits for Alcon |
PTAB Cases with Alcon as patent owner: | See PTAB cases with Alcon as patent owner |
Drugs and US Patents for Alcon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | 10,688,045 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Alcon Labs Inc | CYCLOGYL | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084109-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 11,642,317 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Alcon | ISOPTO CETAPRED | prednisolone acetate; sulfacetamide sodium | SUSPENSION;OPHTHALMIC | 087547-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | 9,827,191 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 9,056,057 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon
Paragraph IV (Patent) Challenges for ALCON drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Ophthalmic Solution | 0.03% | ➤ Subscribe | 2004-12-23 |
➤ Subscribe | Ophthalmic Solution | 0.00% | ➤ Subscribe | 2008-11-28 |
International Patents for Alcon Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Russian Federation | 2563125 | ⤷ Try a Trial |
Denmark | 3811943 | ⤷ Try a Trial |
South Korea | 20180008868 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2015066444 | ⤷ Try a Trial |
South Korea | 20150006869 | ⤷ Try a Trial |
Japan | 2016183198 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0933372 | 13/2008 | Austria | ⤷ Try a Trial | PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713 |
1631293 | 92462 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: BRIMONIDINE ET SES SELS PHARMACEUTIQUES POUR L UTILISATION COMME MEDICAMENT POUR LE TRAITEMENT DES ROUGEURS INDUITES PAR LA ROSACEA.FIRST REGISTRATION: 20140225 |
3043773 | 2190041-0 | Sweden | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE OR A SALT THEREOF AND OLOPATADINE OR A SALT THEREOF; NAT. REG. NO/DATE: MT NR 60226 20210519; FIRST REG.: AT APPROVAL NR 140638 20210426 |
1280520 | C01280520/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012 |
1534313 | 92923 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730 |
0933372 | PA2008006,C0933372 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.